Anna Luisa Schaffgotsch is the Founder and CEO of Impli, a deep-tech medtech company revolutionising female endocrine health. With a background in biotechnology and entrepreneurship, she is leading the development of the world’s first real-time, continuous hormone monitoring platform to optimize outcomes in reproductive health.